Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ:IBB)

159.38 +2.07 (+1.32%)
Official Closing Price Updated: 4:15 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,999,400
Open 156.79
Bid (Size) 157.59 (1)
Ask (Size) 160.00 (4)
Prev. Close 157.31
Today's Range 156.00 - 159.79
52wk Range 107.43 - 159.79
Shares Outstanding N/A
Dividend Yield 0.10%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles
Intellia Therapeutics (NASDAQ: NTLA) paused their Phase 3 MAGNITUDE and MAGNITUDE-2 trials after a serious liver-related adverse event. 
Via Benzinga
SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures
SciSparc traded higher after the company announced it had signed a definitive agreement to acquire a controlling stake in Miza III Ventures. 
Via Benzinga

Performance

YTD
+19.9%
+19.9%
1 Month
+10.4%
+10.4%
3 Month
+20.1%
+20.1%
6 Month
+27.6%
+27.6%
1 Year
+11.9%
+11.9%

More News

Read More
Enpro Moves To Boost Profits With $280 Million Acquisition Push
Via Benzinga
Financial Markets Signal Near 100% Probability of Fed Rate Cut: What it Means for the Economy and Investors
Via MarketMinute
Topics Bonds Credit Cards Economy
White House Clarifies Recent Pharmaceutical Tariffs Exempt Countries with Trade Agreements: Report
Via Stocktwits
Destiny Wealth Sells $8.1 Million in IBB Shares — Here’s Why Biotech Stocks Are Lagging
Via The Motley Fool
Topics Artificial Intelligence ETFs Regulatory Compliance
How Trump's Shutdown Standoff Could Hand Health-Care ETFs A Lifeline
Via Benzinga
Topics ETFs Government
SciSparc And AutoMax Call Off Merger
Via Benzinga
Dallas Fed President Lorie Logan Warns Against Premature Rate Cuts, Prioritizing Inflation Fight
Via MarketMinute
Topics Bonds Credit Cards Economy
CDC Turmoil Escalates: Kennedy To Testify In Senate After Director Fired, Senior Officials Quit
Via Stocktwits
Pharma Tariffs Back In Spotlight On New Trump Threat
Via Investor's Business Daily
Topics ETFs Government World Trade
Small Cap Revival: Could Rate Cuts Spark a Rebound in Smaller Companies?
Via MarketMinute
Topics Economy
Biotech Sector May Flip to Market Leader by Year-End
Via MarketBeat
Topics ETFs Economy Stocks
CDC Chief Susan Monarez Pushed Out After Weeks On Job As RFK Jr. Overhauls Agency — She’s Fighting Back
Via Stocktwits
Trump's Biotech Playbook Ignites $350 Billion Investment Blitz
Via Benzinga
Topics ETFs Government
FDA Is Reportedly ‘Taking A Hard Look’ To Evaluate Whether Sarepta’s Gene Therapy Elevidys Should Remain On The Market
Via Stocktwits
Topics Death
Donald Trump Is Finally Making Good On Pharma Tariffs Threats, But Stocks Yawn
Via Investor's Business Daily
Topics ETFs Government World Trade
Trump Threatens To Slam Pharmaceuticals With Up To 200% Tariffs
Via Investor's Business Daily
Topics ETFs Economy Government
US Supreme Court Reportedly Upholds Part Of Obamacare That Guarantees Health Insurers Cover Preventive Care
Via Stocktwits
Topics Government Lawsuit Religion
Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment
Via Benzinga
Trump Orders FDA To Fast-Track US Drug Production As Tariff Threat Looms On Imported Medicines: Cites National Security Concerns
Via Benzinga
Topics Government World Trade
Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom
Via Talk Markets
Topics ETFs Stocks / Equities
The Major Sector ETFs Got Their Story
Via Talk Markets
Topics ETFs
Major Sector ETFs Break For Easter
Via Talk Markets
Topics Cryptocurrencies ETFs World Trade
RFK Jr.'s Massive Federal Health Workforce Cut Could Take 'Decades To Rebuild,' Warn Experts: 'We Cannot Accurately Assess Whether We Are Truly Making America Healthier'
Via Benzinga
Topics Workforce

Frequently Asked Questions

Is iShares Biotechnology ETF publicly traded?
Yes, iShares Biotechnology ETF is publicly traded.
What exchange does iShares Biotechnology ETF trade on?
iShares Biotechnology ETF trades on the Nasdaq Stock Market
What is the ticker symbol for iShares Biotechnology ETF?
The ticker symbol for iShares Biotechnology ETF is IBB on the Nasdaq Stock Market
What is the current price of iShares Biotechnology ETF?
The current price of iShares Biotechnology ETF is 159.38
When was iShares Biotechnology ETF last traded?
The last trade of iShares Biotechnology ETF was at 10/31/25 04:15 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.